Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
0.3890
+0.0170 (4.57%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Bolt Biotherapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Bolt Biotherapeutics stock have an average target of 1.13, with a low estimate of 1.00 and a high estimate of 1.25. The average target predicts an increase of 190.49% from the current stock price of 0.39.
Analyst Consensus: Hold
* Price targets were last updated on Mar 25, 2025.
Analyst Ratings
The average analyst rating for Bolt Biotherapeutics stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 25, 2025 |
| Stifel | Stifel | Hold Maintains $1.5 → $1.25 | Hold | Maintains | $1.5 → $1.25 | +221.34% | Mar 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 15, 2024 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $3 → $1 | Buy → Hold | Downgrades | $3 → $1 | +157.07% | May 15, 2024 |
Financial Forecast
Revenue This Year
3.87M
from 7.69M
Decreased by -49.71%
Revenue Next Year
6.86M
from 3.87M
Increased by 77.45%
EPS This Year
-1.14
from -1.65
EPS Next Year
-0.79
from -1.14
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.3M | 15.9M | 38.4M | ||
| Avg | 3.9M | 6.9M | 14.0M | ||
| Low | 2.1M | 686,000 | 196,000 |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -31.2% | 311.8% | 459.7% | ||
| Avg | -49.7% | 77.5% | 104.1% | ||
| Low | -73.2% | -82.3% | -97.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.99 | -0.78 | -0.39 | ||
| Avg | -1.14 | -0.79 | -0.49 | ||
| Low | -1.41 | -0.78 | -0.58 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.